MedPage Today |
Top stories in endocrinology: FDA suspends trial involving investigational diabetes drug, issues guidance for blood ...
Healio Among the most-read stories in endocrinology this week was the announcement that the FDA suspended the trial of an investigational drug for treating type 2 diabetes and that the federal agency had issued two draft guidances for blood glucose meters. The Most Wonderful Mistake the FDA Ever Made |
from diabetes - Google News
Social Plugin